Ming Bai

Dr. Ming Bai


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
MBMing Bai
Ming Bai
ALAndong Lu
Andong Lu
CPChenliang Pan
Chenliang Pan
SHSixiong Hu
Sixiong Hu
WQWenjing Qu
Wenjing Qu
BZBo Zhang
Bo Zhang
Background: The safety and feasibility of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as mechanical circulatory support in high-risk percutaneous coronary intervention (HR-PCI) remain unclear.Methods: This retrospective study included patients with complex and high-risk coronary artery disease who underwent elective PCI with VA-ECMO support pre-operatively during March 2019–December 2020. Rates of VA-ECMO-related complications, complications during PCI, death, myocardial infarction, and stroke during hospitalisation and 1-year post-operatively were analysed.Results: Overall, 36 patients (average age: 63.6 ± 8.9 years) underwent PCI. The average duration of VA-ECMO support was 12.5 (range, 3.0–26.3) h. Intra-aortic balloon pump counterpulsation was used in 44.4% of patients. The SYNTAX score was 34.6 ± 8.4 pre-operatively and 10.8 ± 8.8 post-operatively (P < 0.001). Intraoperative complications included pericardial tamponade (N = 2, 5.6%), acute left-sided heart failure (N = 1, 2.8%), malignant arrhythmia requiring electrocardioversion (N = 2, 5.6%), and no deaths. Blood haemoglobin levels before PCI and 24 h after VA-ECMO withdrawal were 145.4 ± 20.2 g/L and 105.7 ± 21.7 g/L, respectively (P < 0.001). Outcomes during hospitalisation included death (N = 1, 2.8%), stroke (N = 1, 2.8%), lower limb ischaemia (N = 2, 5.6%), lower limb deep venous thrombosis (N = 1, 2.8%), cannulation site haematoma (N = 2, 5.6%), acute renal injury (N = 2, 5.6%), bacteraemia (N = 2, 5.6%), bleeding requiring blood transfusion (N = 5, 13.9%), and no recurrent myocardial infarctions. Within 1 year post-operatively, two patients (5.6%) were hospitalised for heart failure.Conclusions: Veno-arterial extracorporeal membrane oxygenation mechanical circulation support during HR-PCI is a safe and feasible strategy for achieving revascularisation in complex and high-risk coronary artery lesions. VA-ECMO-related complications require special attention.

15 July 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
SHSixiong Hu
Sixiong Hu
ALAndong Lu
Andong Lu
CPChenliang Pan
Chenliang Pan
BZBo Zhang
Bo Zhang
YWYong Ling Wa
Yong Ling Wa
MBMing Bai
Ming Bai
Background: This study aimed to summarize and analyse the risk factors, clinical features, as well as prevention and treatment of limb ischemia complications in patients on veno-arterial extracorporeal membrane oxygenation (V-A ECMO).Methods: We retrospectively analyzed 179 adult patients who had undergone V-A ECMO support in the Cardiac Care Unit of the First Hospital of Lanzhou University between March 2019 and December 2021. Patients were divided into the limb ischemia group (LI group) and the non-limb ischemia group (nLI group) according to whether limb ischemia occurred on the ipsilateral side of femoral artery cannulation. In the LI group, patients were salvaged with a distal perfusion cannula (DPC) according to each patient's clinical conditions. The baseline data and ECMO data were compared between the two groups, and risk factors for limb ischemia complications were screened using multiple logistic regression analysis.Results: Overall, 19 patients (10.6%) had limb ischemia complications, of which 5 (2.8%) were improved after medication adjustment, 12 (8.4%) were salvaged with a DPC, and 2 had undergone surgical intervention. There were significant differences in terms of Extracorporeal Cardiopulmonary Resuscitation (ECPR), Intra-aortic balloon pump (IABP), peak vasoactive-inotropic score (VIS) within 24 h after ECMO (VIS-max), Left ventricular ejection fraction (LVEF), weaning from ECMO, and discharge rate between the two groups. ECPR, IABP, and VIS-max in the LI group were significantly higher than those in the nLI group, whereas weaning from ECMO, discharge rate, and LVEF were significantly lower in the LI group compared to those in the nLI group. Furthermore, multiple logistic regression analysis revealed that diabetes [odds ratio (OR) = 4.338, 95% confidence interval (CI): 1.193–15.772, P = 0.026], IABP (OR = 1.526, 95% CI: 1.038–22.026, P = 0.049) and VIS-max (OR = 1.054, 95% CI: 1.024–1.085, P < 0.001) were independent risk factors for limb ischemia complications in patients who underwent V-A ECMO.Conclusion: Diabetes, prevalence of IABP and VIS-max value in analyzed groups were independent risk factors for predicting limb ischemia complications in patients who underwent V-A ECMO. The cannulation strategy should be optimized during the establishment of V-A ECMO, and limb ischemia should be systematically evaluated after ECMO establishment. A DPC can be used as a salvage intervention for the complications of critical limb ischemia.

22 July 2025 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
JLJiawei Li
Jiawei Li
毛赵毛毛 赵
毛毛 赵
LBLu Bai
Lu Bai
JZJing Zhao
Jing Zhao
HGHanxiang Gao
Hanxiang Gao
MBMing Bai
Ming Bai
The relationship between inflammation and atrial fibrillation (AF) has recently attracted significant research interest. Epicardial adipose tissue (EAT) contributes to the pathogenesis of AF through its inflammatory, metabolic, and electrophysiological effects and may also influence AF outcomes. Inflammatory cells within EAT release key proinflammatory cytokines, including interleukin (IL)-1β and tumor necrosis factor-α (TNF-α), which promote cardiomyocyte apoptosis and fibrosis. These changes compromise cardiac electrophysiological stability and elevate the risk of arrhythmias. Moreover, increased EAT thickness and volume have been identified as critical biomarkers for AF risk, providing new insights into AF diagnosis and treatment. However, despite compelling evidence of a strong association between EAT and AF, further studies are needed to fully elucidate the mechanisms underlying the role of EAT and assess its potential as a therapeutic target. This review aimed to explore the specific mechanisms of inflammation-related EAT in AF and evaluate the clinical potential of EAT as a biomarker and therapeutic target.

22 August 2025 in JACC: Advances
Verified
Journal Article
Open access
CPChenliang Pan
Chenliang Pan
YZYouqi Zhu
Youqi Zhu
JZJing Zhao
Jing Zhao
BZBo Zhang
Bo Zhang
SHSixiong Hu
Sixiong Hu
MBMing Bai
Ming Bai
Evidence on prophylactic venoarterial extracorporeal membrane oxygenation (VA-ECMO) during elective percutaneous coronary intervention (PCI) in patients with complex high-risk coronary artery lesions is limited. The authors aimed to assess the safety and effectiveness of prophylactic VA-ECMO during PCI. This single-center, randomized trial enrolled 70 patients with complex high-risk coronary lesions (Synergy Between PCI with Taxus and Cardiac Surgery [SYNTAX] score ≥33) who declined coronary artery bypass grafting. Patients were divided into those who had prophylactic VA-ECMO (n = 34) prior to PCI and controls who did not have prophylactic VA-ECMO (n = 36). Elective PCI was performed, and complications were recorded. Life-threatening complications included: 1) cardiac arrest unresponsive to cardiopulmonary resuscitation; 2) cardiogenic shock; 3) acute left heart failure unresponsive to therapy; and 4) refractory malignant arrhythmias. SYNTAX scores pre- and post-PCI were calculated. The primary endpoints were the rate of complications during PCI and SYNTAX score reduction post-PCI. Between June 2021 and August 2023, 70 patients (women: 14.3%) underwent PCI. SYNTAX scores in the VA-ECMO and control group were similar (37.8 [34.5-44.0] vs 35.8 [33.2-40.8], P = 0.11). Life-threatening complications were lower in the VA-ECMO group compared to controls (0% vs 19.4%; P = 0.01). Emergency VA-ECMO was required in 19.4% of the control group. The VA-ECMO group showed greater absolute reduction in SYNTAX scores (27.2 [24.5-35.0] vs 22.5 [11.5-32.8], P = 0.04). In this single-center study of patients undergoing elective PCI of complex high-risk coronary lesions, prophylactic VA-ECMO was associated with lower rates of life-threatening complications and larger reduction in SYNTAX scores. Larger studies are needed to further define optimal management strategies in high-risk complex PCI.

2 January 2026 in JMIR Formative Research
Verified
Journal Article
Open access
ZYZi Yang
Zi Yang
XWXiaojuan Wang
Xiaojuan Wang
JWJianlin Wang
Jianlin Wang
QGQi Guang
Qi Guang
XDXueqian Ding
Xueqian Ding
MBMing Bai
Ming Bai
Background: Cardiovascular diseases remain the leading global cause of mortality, yet traditional electrocardiogram (ECG) interpretation shows subjective variability and limited sensitivity to complex pathologies. Objective: This study aims to address these challenges by proposing the Cardiovascular Multimodal Prediction Network (CaMPNet), a transformer-based multimodal architecture that integrates raw 12-lead ECG waveforms, 9-structured machine-measured ECG features, and demographic data (age and sex) through cross-attention fusion. Methods: The model was trained on 384,877 records from the Medical Information Mart for Intensive Care IV - Electrocardiogram Matched Subset database and evaluated across 12 cardiovascular disease labels. To further assess temporal robustness, a temporal external validation was performed using the most recent 10% of the data, withheld chronologically from model development. Results: On the internal test set, the model achieved a mean area under the curve (AUC) of 0.845 (SD 0.04) and area under the precision-recall curve of 0.489, outperforming the residual networks-ECG baseline (AUC=0.848 but F 1 - score=0.152) and all single-modality variants. Subgroup analyses demonstrated consistent performance across demographics (male AUC= 0.846 vs female=0.843; youngest quartile 0.884 vs oldest 0.811). CaMPNet retained moderate discriminative ability in temporal external validation with a mean AUC of 0.715 (SD 0.03) and area under the precision-recall curve of 0.298, although performance declined due to temporal distribution shifts. Despite this, major disease categories, such as atrial fibrillation, heart failure, and normal rhythm, maintained high AUCs (>0.84). Attention-based visualization revealed clinically interpretable patterns (eg, ST-segment elevations in ST-segment elevation myocardial infarction), and ablation experiments verified the model’s tolerance to missing structured inputs. Conclusions: CaMPNet demonstrates robust and interpretable multimodal ECG-based diagnosis, offering a scalable framework for comorbidity screening and continual learning under real-world temporal dynamics.

18 April 2023 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
ZLZekun Lang
Zekun Lang
YZYouqi Zhu
Youqi Zhu
GJGaxue Jiang
Gaxue Jiang
PJPengfei Ji
Pengfei Ji
XZXiaoqi Zhang
Xiaoqi Zhang
MBMing Bai
Ming Bai
Background: To assess whether there are differences in common postoperative complications and survival between men and women after transcatheter aortic valve implantation. Methods: We searched the Cochrane Library, PubMed, Embase, and the Web of Science from January 2000 to August 2022. Gender-related articles reporting complications and mortality after transcatheter aortic valve implantation were identified. The primary outcomes were the thirty-day mortality, one-year mortality and perivalvular leakage. The secondary outcomes were conversion to open heart surgery during operation, ejection fraction after operation, reintervention and other common postoperative complications. Data were pooled using the risk ratio or standardized mean difference with 95% confidence interval. Subgroup analysis, meta-regression, sensitivity analysis, egger’s test and begg’s test were performed. The original study protocol was registered prospectively with PROSPERO (CRD42021245858). Results: There were 24 studies, a total of 92,499 patients, enrolled in our systematic review and meta-analysis, including 43,948 men and 48,551 women. Comprehensive analysis showed significant differences in gender in postoperative complications and survival after transcatheter aortic valve implantation. Men had a significantly higher risk of perivalvular leakage (risk ratio (RR) = 1.42; 95% CI: 1.15 to 1.75; p = 0.001; I2 = 68%), but lower risk in bleeding (RR = 0.69; 95% CI: 0.61 to 0.79; p < 0.00001; I2 = 82%), vascular complications (RR = 0.56; 95% CI: 0.52 to 0.61; p < 0.00001; I2 = 48%), and stroke (RR = 0.86; 95% CI: 0.80 to 0.93; p < 0.00001; I2 = 12%). The thirty-day mortality of men is slightly lower than that of women (RR = 0.87; 95% CI: 0.81 to 0.93; p = 0.0001; I2 = 47%), the difference in one-year mortality was also significant (RR = 1.20; 95% CI: 1.08 to 1.33; p = 0.0008; I2 = 59%). Univariate meta-regression analyses showed that pulmonary hypertension is the major source of heterogeneity in bleeding. Conclusions: Men after transcatheter aortic valve implantation have a lower risk of related postoperative complications, but a higher risk of paravalvular leak and no advantage in medium-term survival.